SFI
NEO icon

Susquehanna Fundamental Investments’s NeoGenomics NEO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-43,288
Closed -$680K – 987
2024
Q1 		$680K Buy
+43,288
New +$668K 0.03% 416
2022
Q1 		$349K Hold
28,711
– – 0.01% 1205
2021
Q4 		$980K Sell
28,711
-24,060
-46% -$942K 0.03% 665
2021
Q3 		$2.55M Buy
+52,771
New +$2.44M 0.05% 522

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna Fundamental Investments's NEO Position: Q2 2024 in Review

Susquehanna Fundamental Investments sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 43,288 shares — an estimated $680K sold.

Susquehanna Fundamental Investments first reported a position in NEO in Q3 2021 and held it in 4 quarters. The position peaked at $2.55M in Q3 2021. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Susquehanna Fundamental Investments reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 43,288 NeoGenomics shares in Q2 2024, an estimated $680K.
  • Susquehanna Fundamental Investments first reported a position in NeoGenomics in Q3 2021 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's NeoGenomics position peaked at $2.55M in Q3 2021.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.